ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1469	National Cancer Institute	Html	en	Adult Central Nervous System Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult central nervous system tumors.	type anaplastic astrocytomas 0.549962 5-year analysis 0.459034 rapid immunohistochemical analysis 0.458442 mutations aids diagnosis 0.4781 adjuvant temozolomide 0.53303 BRAF genetic alterations 0.471994 pontine gliomas 0.467631 concurrent radiation therapy 0.474706 MGMT promoter methylation 0.572789 Radiation Therapy Oncology 0.484458 oligodendroglial tumors 0.468432 adult high-grade glioma 0.464776 Nervous System Tumors 0.717497 Astrocytic Tumors Treatment 0.922097 diffuse astrocytomas 0.480334 prognostic factor 0.47815 patients 0.62456 Primary Central Nervous 0.835704 Tumor Type section 0.826321 low-grade gliomas 0.476475 randomized trials 0.48238 anaplastic gliomas 0.467716 Treatment Option Overview 0.469049 standard systemic chemotherapy 0.485413	mutant tumors 0.500547 malignant gliomas 0.567609 radiation therapy 0.833741 standard chemotherapy agent 0.48857 Lancet Oncol 0.46722 glioblastoma patients 0.504986 Radiation Therapy section 0.489765 deep-seated tumors 0.489355 Glioblastomas treatment section 0.511285 diffuse gliomas 0.494198 CNS tumors 0.489107 strong prognostic factor 0.47196 primary malignant glioma 0.474955 DNA repair enzyme 0.549791 standard local treatment 0.596897 Low-grade tumors 0.493795 oral agent temozolomide 0.522443 pilocytic astrocytomas 0.562223 particular glioma subtypes 0.489447 newly diagnosed glioblastoma 0.602836 activating point mutation 0.473461 Tumors Treatment section 0.972163 mutant-specific IDH1 antibody 0.464835 potential diagnostic utility 0.459778	CLICK HERE
1483	National Cancer Institute	Html	en	Kaposi Sarcoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Kaposi sarcoma.	classic ks 0.718451 azathioprine developed KS 0.600594 skin surface area 0.47235 systemic lesions 0.493932 indolent course 0.470841 mucocutaneous lesions 0.512302 renal transplant 0.501016 visceral lesions 0.497461 KS involvement 0.562512 KS incidence 0.560945 KS lesions 0.599331 Pleuropulmonary KS 0.5556 HIV disease patients 0.521452 relatively common neoplasm 0.471596 widespread mucocutaneous lesions 0.507995 patients 0.634408 renal transplant patient 0.470087 drug-resistant HIV strains 0.474114 immunosuppressive therapy 0.478552 lymph nodes 0.596884 renal transplant patients 0.496667 gastrointestinal tract 0.58589 rare disease 0.483334 classic KS tumor 0.622697 detectable visceral organ 0.475328	iatrogenically immunosuppressed patients 0.494142 numerous lesions 0.474766 opportunistic infections 0.508602 HIV disease 0.544402 gastrointestinal tract disease 0.488821 KS treatment 0.552981 innumerable skin lesions 0.514662 standard tumor assessment 0.472883 visceral organ involvement 0.584749 disease 0.576658 African KS 0.57237 AIDS patients 0.479351 epidemic KS die 0.595228 classical KS 0.550709 rapidly progressive tumor 0.472892 KS 0.931586 Classic KS tumors 0.625414 generalized KS 0.572002 skin disease 0.482408 epidemic KS 0.750866 skin lesions 0.586652 additional lesions 0.488289 nodular skin lesions 0.53343 biopsy-proven KS 0.558149	CLICK HERE
1614	National Cancer Institute	Html	en	Small Intestine Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of small intestine cancer.	treatment 0.474663 cancer treatment 0.28121 general information 0.207525 biologic therapy 0.208552 new cancer treatments 0.211372 NCI-supported cancer 0.201612 cancer cells 0.363757 small intestine leiomyosarcoma 0.321766 body 0.259153 Cancer Information Service 0.211251 PDQ cancer information 0.323637 clinical trial search 0.240948 intestine cancer spreads 0.326211 treatment clinical trials 0.247389 National Cancer Institute 0.281738 clinical trials 0.768713 small bowel 0.209407 cancer information summary 0.278324 clinical trial 0.582681	new treatment 0.286343 small intestine adenocarcinoma 0.324343 External radiation therapy 0.208562 patients 0.225884 Blood. The cancer 0.205393 large intestine 0.315511 treatment clinical trial 0.212129 NCI PDQ cancer 0.228818 cancer research process 0.201049 new anticancer drugs 0.248329 cancer clinical trials 0.271351 lymph nodes 0.209989 tumor 0.247188 radiation therapy 0.498101 Treatment Editorial Board 0.224109 cancer information summaries 0.209407 small intestine cancer 0.951217 comprehensive cancer information 0.20938 standard treatment 0.222923	CLICK HERE
1791	National Cancer Institute	Html	es	Fatiga (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de la fatiga, una afección caracterizada por extremo cansancio e incapacidad para funcionar por la falta de energía, que a menudo se observa como una complicación del cáncer y su tratamiento.	siguientes procedimientos 0.385633 anemia.Los análisis 0.341771 siguientes elementos 0.380985 descanso ayuda 0.330891 suficientes glóbulos 0.429586 siguientes hábitos 0.360426 fatiga mejora 0.961013 siguientes razones 0.406276 Mayor sentimiento 0.336513 causa anemia 0.447908 Más capacidad 0.391264 siguientes beneficios 0.36204 período intermedio 0.361444 terapia ayuda 0.331417 largo plazo 0.508126 menor cantidad 0.379836 suficiente oxígeno 0.364828 horarios regulares 0.332634 siguientes síntomas 0.40531 National Cancer Institute 0.337934 siguientes riesgos 0.339715 Mejor calidad 0.332342	paciente formas 0.386322 Terapia respiratoria 0.332012 vitamina b12 0.347342 Instituto Nacional 0.366294 insuficiente cantidad 0.340569 siguientes problemas 0.399021 suficientes calorías 0.375086 Insuficiente apoyo 0.328686 siguientes factores 0.398895 Physician Data Query 0.439181 suficientes alimentos 0.42156 mayores probabilidades 0.359824 PDQ Fatiga 0.692467 Mejor apetito 0.341698 PDQ Trastornos 0.417003 posibles causas 0.332899 siguientes medicamentos 0.4009 general aumenta 0.350637 desesperanza frente 0.332953 menudo causa síntomas 0.432855 paciente preste atención 0.49209	CLICK HERE
1824	National Cancer Institute	Html	es	Tratamiento del cáncer epitelial de ovario, de trompas de Falopio y primario de peritoneo (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer epitelial de ovario, de trompas de Falopio y primario de peritoneo.	Obstet Gynecol 0.328674 adjuvant chemotherapy 0.316668 chemotherapy in ovarian 0.322043 prognostic factors 0.308986 pacientes portadores 0.306542 crecimiento infiltrante destructor 0.31512 American Cancer Society 0.31686 Breast Cancer Linkage 0.317976 Mol Cancer Ther 0.309108 estadio temprano cirugía 0.310703 Ovarian Cancer Registry 0.325508 Cancer Res 0.30945 Cancer Linkage Consortium 0.317364 ovarian cancer 0.973902 randomized trial 0.311991 FIGOa Estadio Definición 0.307321 ovarian carcinoma 0.378303 adjuvant chemotherapy in 0.315561 Natl Cancer Inst 0.350243 International Collaborative Ovarian 0.315389 Gynecologic Oncology Group 0.347704 Collaborative Ovarian Neoplasm 0.316238 Radner Familial Ovarian 0.312567 Gynecol Oncol 0.326661 patients with 0.315269	Metástasis peritoneales macroscópicas 0.307056 estadio iv 0.341957 estadio ii 0.434604 peritoneo estadio opciones 0.310058 Cancer Facts 0.309636 estadio ic 0.320607 estadio ib 0.307072 estadio ia 0.317155 Ovarian carcinoma diagnosis 0.308469 Oncology Group study 0.306421 Young RC 0.307696 familial ovarian cancer 0.336296 Brady MF 0.306168 estadio iia 0.314327 treated with cisplatin-based 0.308377 Clin Oncol 0.327391 Ovarian Neoplasm 0.324824 breast cancer 0.321408 in ovarian 0.344499 in ovarian neoplasm 0.319834 quimioterapia adyuvante versus 0.306417 estadio iii 0.330381 with cisplatin-based chemotherapy 0.310441 treated with 0.312964	CLICK HERE
1839	National Cancer Institute	Html	es	Tratamiento de los tumores del sistema nervioso central en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores del sistema nervioso central en adultos.	carmustina versus 0.548633 malignant glioma 0.86408 WB Saunders Co 0.553184 American Cancer Society 0.574098 sumario tratamiento 0.554962 cuáles pacientes 0.551482 primary gliomas located 0.577278 idh1 mutation 0.550619 IDH2 mutations 0.547874 Radiation Therapy Oncology 0.556783 Radiat Oncol Biol 0.675252 central nervous system 0.6889 patients with 0.664355 Medical Research Council 0.587686 Brain Tumor Research 0.559245 Acta Neuropathol 0.563339 cerebral low-grade glioma 0.542243 diagnosed malignant glioma 0.650146 who classification 0.562467 Neuroimaging Clin 0.54527 chemotherapy with 0.549687 patients with glioblastoma 0.549124 tumor group study 0.541376 Organización Mundial 0.549658 Research Council Brain 0.538383	malignant glioma after 0.544669 Cancer Treatment 0.573642 Ohgaki H 0.558609 mortalidad posoperatoria 0.540841 patients with idh1 0.548495 Bent MJ 0.548927 Therapy Oncology Group 0.603297 radioterapia posoperatoria 0.576011 BRAF V600E 0.543097 low-grade glioma 0.559845 primary malignant glioma 0.547729 conventional radiotherapy with 0.572491 National Cancer Institute 0.578026 radiotherapy with 0.578973 newly diagnosed malignant 0.564043 características histológicas 0.717766 Radiation-induced malignant gliomas 0.578762 Clin Oncol 0.624379 sistema nervioso central 0.979769 brain tumor 0.782394 Oncol Biol Phys 0.679866 adult brain tumors 0.545694 Cancer Institute 0.592793 brain tumour 0.610029	CLICK HERE
1892	National Cancer Institute	Html	es	Tratamiento del cáncer de estómago (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de estómago.	siguientes procedimientos 0.623574 estadio iv 0.777016 siguientes aspectos 0.573343 proteína vegf 0.350025 siguientes afecciones 0.419234 genes her2 0.549019 exploraciones tep 0.370808 siguientes tipos 0.374337 cuerpo llamada 0.407415 rayos x 0.496347 estadio ib 0.603838 estadio ia 0.601417 enlace drugs approved 0.548214 escáner tep 0.371104 ondas sonoras 0.369553 estómago her2 0.993806 proteína her2 0.939635	siguientes síntomas 0.405764 National Cancer Institute 0.33929 siguientes riesgos 0.335926 Instituto Nacional 0.373632 PDQ Tratamiento 0.63434 estadio iiia 0.59215 estadio iiic 0.584608 estadio iiib 0.586796 estadio iia 0.603101 estadio iib 0.602062 partes distantes 0.357123 Physician Data Query 0.452253 antígeno carcinoembrionario 0.374755 Prueba ACE 0.36171 siguientes sumarios 0.457366 siguientes pruebas 0.405163	CLICK HERE
1970	National Cancer Institute	Html	es	Tratamiento del cáncer de paratiroides (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de paratiroides.	glándula tiroides 0.438865 Más sed 0.410088 siguientes procedimientos 0.457489 contraste circula 0.409886 glándula hiperactiva 0.421803 vía oral 0.406242 rayos x 0.425707 pequeñas marcas 0.406116 National Cancer Institute 0.40574 siguientes riesgos 0.40413 endocrina múltiple tipo 0.418977 Instituto Nacional 0.410629 malla ayuda 0.405988	hormona paratiroidea 0.66472 PDQ Tratamiento 0.41212 cabo pruebas 0.412201 glándulas paratiroides 0.84566 cuál glándula paratiroides 0.475528 Physician Data Query 0.422464 glándula paratiroides 0.975564 glándula paratiroides hiperactiva 0.533736 HPT ayuda 0.413459 toma imágenes 0.439925 siguientes pruebas 0.41438 largo tiempo 0.406983 siguientes trastornos 0.411735	CLICK HERE
3439	National Cancer Institute	Html	es	Exámenes de detección del cáncer de estómago (gástrico) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de estómago (gástrico).	Visuals Online 0.546235 PDQ Exámenes 0.690831 siguientes efectos 0.595148 Physician Data Query 0.831228 siguientes afecciones 0.665794 Estados Unidos 0.968946 siguientes personas 0.608962 rayos x 0.591974 prevención revisa 0.557627	América Central 0.603242 principal causa 0.614774 información ayuda 0.567593 National Cancer Institute 0.581719 siguientes riesgos 0.571014 siguientes sumarios 0.754212 vitamina b12 0.617718 Instituto Nacional 0.653888	CLICK HERE
4390	National Cancer Institute	Html	en	Tobacco	null	safe level 0.460816 death 0.358553 Monday 0.354828 throat 0.333618 cause 0.328958 stomach 0.336801 LiveHelp pop-up 0.465489 kidney 0.330373 acute myeloid leukemia 0.608856 Friday 0.35571 pancreas 0.384789 smoking 0.405609 harms 0.335823 tobacco 0.963237 damage DNA 0.469968 cessation counselors 0.452946 secondhand smoke 0.632466 chemicals 0.330701 cervix 0.34121 tobacco product 0.60509 a.m. 0.346985 types 0.328829	confidential information 0.439568 liver 0.32937 People 0.42541 cancer diagnosis 0.44607 p.m. 0.346876 environmental tobacco smoke 0.826608 substantial gains 0.462279 ET 0.353868 life expectancy 0.459232 lung 0.329921 tobacco products 0.728115 smokeless tobacco 0.623945 snuff 0.336877 mouth 0.374264 NCI quitline 0.460061 bladder 0.333336 colon 0.333223 cancers 0.332967 online 0.346425 cancer 0.481797 risk 0.357987 rectum 0.343994	CLICK HERE